ATE326219T1 - Verwendung von aryl-cyclohexylamine derivaten zur herstellung von nmda-rezeptorblockern - Google Patents

Verwendung von aryl-cyclohexylamine derivaten zur herstellung von nmda-rezeptorblockern

Info

Publication number
ATE326219T1
ATE326219T1 AT99115114T AT99115114T ATE326219T1 AT E326219 T1 ATE326219 T1 AT E326219T1 AT 99115114 T AT99115114 T AT 99115114T AT 99115114 T AT99115114 T AT 99115114T AT E326219 T1 ATE326219 T1 AT E326219T1
Authority
AT
Austria
Prior art keywords
aryl
producing
nmda receptor
receptor blockers
cyclohexylamine derivatives
Prior art date
Application number
AT99115114T
Other languages
English (en)
Inventor
Alexander Alanine
Bernd Buettelmann
Neidhart Marie-Paule Heitz
Emmanuel Pinard
Rene Wyler
Original Assignee
Hoffmann La Roche
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Hoffmann La Roche filed Critical Hoffmann La Roche
Application granted granted Critical
Publication of ATE326219T1 publication Critical patent/ATE326219T1/de

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/535—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one oxygen as the ring hetero atoms, e.g. 1,2-oxazines
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A61K31/445—Non condensed piperidines, e.g. piperocaine
    • A61K31/451—Non condensed piperidines, e.g. piperocaine having a carbocyclic group directly attached to the heterocyclic ring, e.g. glutethimide, meperidine, loperamide, phencyclidine, piminodine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/13—Amines
    • A61K31/135—Amines having aromatic rings, e.g. ketamine, nortriptyline
    • A61K31/137—Arylalkylamines, e.g. amphetamine, epinephrine, salbutamol, ephedrine or methadone
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/13—Amines
    • A61K31/135—Amines having aromatic rings, e.g. ketamine, nortriptyline
    • A61K31/138—Aryloxyalkylamines, e.g. propranolol, tamoxifen, phenoxybenzamine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/16—Amides, e.g. hydroxamic acids
    • A61K31/18—Sulfonamides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • A61K31/357—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having two or more oxygen atoms in the same ring, e.g. crown ethers, guanadrel
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
    • A61P25/16—Anti-Parkinson drugs
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/26—Psychostimulants, e.g. nicotine, cocaine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Epidemiology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Neurosurgery (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • Emergency Medicine (AREA)
  • Psychology (AREA)
  • Psychiatry (AREA)
  • Hospice & Palliative Care (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Hydrogenated Pyridines (AREA)
  • Heterocyclic Compounds That Contain Two Or More Ring Oxygen Atoms (AREA)
AT99115114T 1998-08-18 1999-08-09 Verwendung von aryl-cyclohexylamine derivaten zur herstellung von nmda-rezeptorblockern ATE326219T1 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
EP98115484 1998-08-18

Publications (1)

Publication Number Publication Date
ATE326219T1 true ATE326219T1 (de) 2006-06-15

Family

ID=8232474

Family Applications (1)

Application Number Title Priority Date Filing Date
AT99115114T ATE326219T1 (de) 1998-08-18 1999-08-09 Verwendung von aryl-cyclohexylamine derivaten zur herstellung von nmda-rezeptorblockern

Country Status (24)

Country Link
US (1) US6184236B1 (de)
JP (1) JP3455142B2 (de)
KR (1) KR100341194B1 (de)
CN (1) CN1141936C (de)
AR (1) AR021770A1 (de)
AT (1) ATE326219T1 (de)
AU (1) AU756408B2 (de)
BR (1) BR9903779A (de)
CA (1) CA2280455A1 (de)
DE (1) DE69931316D1 (de)
HR (1) HRP990256A2 (de)
HU (1) HUP9902737A3 (de)
ID (1) ID23107A (de)
IL (1) IL131399A0 (de)
MA (1) MA26677A1 (de)
MY (1) MY133133A (de)
NO (1) NO993948L (de)
NZ (1) NZ337243A (de)
PE (1) PE20000955A1 (de)
PL (1) PL334949A1 (de)
SG (1) SG82014A1 (de)
TR (1) TR199902015A3 (de)
YU (1) YU38699A (de)
ZA (1) ZA995212B (de)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU2001263130A1 (en) * 2000-06-06 2001-12-17 Warner Lambert Company Bicyclic cyclohexylamines and their use as nmda receptor antagonists
US7375136B2 (en) * 2001-03-08 2008-05-20 Emory University pH-dependent NMDA receptor antagonists
DE10153345A1 (de) * 2001-10-29 2003-05-08 Gruenenthal Gmbh Substituierte 1H-Chinoxalin-2-on-Verbindungen und substituierte 4-Aryl- und 4-Heteroarylcyclohexan-Verbindungen
US20070004805A1 (en) * 2005-07-01 2007-01-04 Navinta Llc Process for preparation of liquid dosage form containing sodium 4-phenylbutyrate
EA201070077A1 (ru) * 2007-06-29 2010-08-30 Эмори Юниверсити Антагонисты nmda-рецепторов с нейропротективным действием

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE4032766A1 (de) 1990-10-16 1992-04-30 Basf Ag Phenylpiperidinoylamine und diese enthaltende arzneimittel
DE4117904A1 (de) 1991-05-31 1992-12-03 Basf Ag Substituierte n-phenylpiperidine
ATE130851T1 (de) 1991-03-14 1995-12-15 Basf Ag Substituierte n-phenylpiperidine und arzneimittel daraus.
WO1997015549A1 (en) 1995-10-26 1997-05-01 Tokyo Tanabe Company Limited PHENYLETHANOLAMINE COMPOUNDS USEFUL AS β3 AGONIST, PROCESS FOR PRODUCING THE SAME, AND INTERMEDIATES IN THE PRODUCTION OF THE SAME

Also Published As

Publication number Publication date
KR20000017343A (ko) 2000-03-25
PL334949A1 (en) 2000-02-28
PE20000955A1 (es) 2000-09-28
TR199902015A2 (xx) 2000-03-21
CA2280455A1 (en) 2000-02-18
BR9903779A (pt) 2000-09-19
AU4453799A (en) 2000-05-04
KR100341194B1 (ko) 2002-06-20
TR199902015A3 (tr) 2000-03-21
DE69931316D1 (de) 2006-06-22
HRP990256A2 (en) 2000-04-30
JP3455142B2 (ja) 2003-10-14
CN1248439A (zh) 2000-03-29
AU756408B2 (en) 2003-01-09
US6184236B1 (en) 2001-02-06
NO993948L (no) 2000-02-21
HUP9902737A3 (en) 2001-01-29
JP2000109429A (ja) 2000-04-18
HU9902737D0 (en) 1999-10-28
ID23107A (id) 2000-02-24
ZA995212B (en) 2000-02-18
MY133133A (en) 2007-10-31
NZ337243A (en) 2000-12-22
NO993948D0 (no) 1999-08-17
IL131399A0 (en) 2001-01-28
SG82014A1 (en) 2001-07-24
CN1141936C (zh) 2004-03-17
MA26677A1 (fr) 2004-12-20
YU38699A (sh) 2002-03-18
AR021770A1 (es) 2002-08-07
HUP9902737A2 (hu) 2000-06-28

Similar Documents

Publication Publication Date Title
DE69909490D1 (de) Autothermisches verfahren zur herstellung von olefinen
ATE232855T1 (de) Verfahren zur herstellung von derivaten der taxoid-klasse
DE69900794D1 (de) Herstellung von halbsandwich substituierten katalysator-vorläufern
DE69814862D1 (de) Verfahren zur herstellung von pyridinderivaten
DE69916725D1 (de) Vorrichtung zur herstellung von zement
DE69918781D1 (de) Die verwendung von tee-polyphenolen zur herstellung von anti-chlamydia mitteln
DE69813869T2 (de) Verfahren zur herstellung von thiazolidindion-derivaten
ATE359285T1 (de) Verwendung von scopinester derivaten zur herstellung von arzneimitteln
DE69905313D1 (de) Verfahren zur Herstellung von 4-substituierten Azetidinon-Derivaten
DE69909821D1 (de) Verfahren zur herstellung von weichem seidenpapier
DE69922558D1 (de) Herstellung von Aluminiumoxid
ATE326219T1 (de) Verwendung von aryl-cyclohexylamine derivaten zur herstellung von nmda-rezeptorblockern
ATE224367T1 (de) Verfahren zur herstellung von indolderivaten
ATE219056T1 (de) Verfahren zur herstellung von alpha- bromolactamderivaten
DE69727674D1 (de) Zur herstellung von gebrannten mustern
DE59811806D1 (de) Verwendung von ausgewählten phytostenolestern zur herstellung von hypocholesterinämischen mitteln
DE69943388D1 (de) Verfahren zur herstellung von tonern
DE69902755D1 (de) Verfahen zur herstellung von styrolen
DE69902120D1 (de) Verfahren zur Herstellung von Acetylenderivaten
ATE235331T1 (de) Verfahren zur herstellung von keramikformen
ATE314070T1 (de) Verwendung von pyridoindolonderivaten zur herstellung von antikrebsmitteln
NO20011480D0 (no) FremgangsmÕte for fremstilling av (-)<alfa>-
ATE255889T1 (de) Verwendung von beta-3-adrenorezeptoragonisten zur herstellung von wundheilmitteln
ATA45299A (de) Verfahren zur herstellung von oxcarbazepin
DE69900543D1 (de) Verfahren zur herstellung von 2-aminothiazolcarboxamidderivaten

Legal Events

Date Code Title Description
RER Ceased as to paragraph 5 lit. 3 law introducing patent treaties